More Articles

Battle rages over anti-thrombotic medicine Biosimilars/News | Posted 10/11/2011

Sandoz/Momenta are ahead again in the fight for the lucrative anticoagulants market in the US. According to IMS Health data enoxaparin sodium injection is the best-selling hospital medicine in the...

AstraZeneca settles patent dispute over Seroquel XR Generics/News | Posted 10/11/2011

In an out-of-court deal, AstraZeneca has agreed with Accord Healthcare, Handa Pharmaceuticals and Intas Pharmaceuticals that the latter can sell generic forms of the antipsychotic blockbuster Seroq...

Merck acquires follow-on Copaxone NBCD: determined to lead in MS Biosimilars/General | Posted 10/11/2011

Germany-based Merck already markets its own multiple sclerosis (MS) drug Rebif (interferon beta-1a) but suffered a major blow during 2011 when regulators on both sides of the Atlantic rejected...

Sun Pharma offers to buy remaining Taro shares Pharma News | Posted 10/11/2011

Taro Pharmaceutical Industries confirmed that it had received a letter on 19 October 2011 from Sun Pharma offering to buy all outstanding shares of Taro, not currently held by Sun Pharma, at a pric...

Generics will grab Parkinson’s disease market share Reports | Posted 10/11/2011

Overall sales for Parkinson’s disease drugs in seven major countries will decline slightly from US$2.7 billion in 2010 to US$2.6 billion in 2020 in France, Germany, Italy, Japan, Spain, the UK and...

Obama’s fresh attempts to ease drugs shortages in the US Pharma News | Posted 04/11/2011

Action by the PresidentPresident Barack Obama signed an executive order 31 October 2011 to address an escalating shortage of life-saving medicines, his newest effort to advance social and economic...

Translational research to uncover new uses for generics Generics/Research | Posted 04/11/2011

On the surface, generic compounds and translational medicines could not appear more different. However, in April 2011, the US National Institutes of Health (NIH) met with academic, governmental, an...

Can biosimilar manufacturers learn from generic substitution issues Biosimilars/Research | Posted 04/11/2011

The substitution of generic prescription medicines for branded medicines is practiced in most Westernised countries, mainly because of its clear economic benefits. Patient experiences of generic su...